Nanomaterials in Cosmetics: Regulatory Aspects

Diana Bowman, Nathaniel D. May, Andrew Maynard

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

This chapter examines existing regulatory structures for cosmetic products containing nanomaterials. It does this by first providing a snapshot of the types of nanomaterials that are being incorporated into today's cosmetic products, and the potential benefits thereof. Second, by drawing on the current and projected cosmetic product landscape, it examines how these products fit under existing regulatory arrangements within the United States (US) and the European Union (EU)-the two largest cosmetics markets in the world (by dollar value). As the chapter shows, there is no one-size-fits-all approach to regulating a class of product, and factors beyond just science and scientific uncertainty will drive the design and implementation of a regulatory regime. This is arguably more so, though, with nanotechnology in the US and the EU, given the historical context in which nano-based products are being placed.

Original languageEnglish (US)
Title of host publicationAnalysis of Cosmetic Products
Subtitle of host publicationSecond Edition
PublisherElsevier
Pages289-302
Number of pages14
ISBN (Electronic)9780444635167
ISBN (Print)9780444635082
DOIs
StatePublished - Nov 17 2017

Fingerprint

Nanomaterials
European Union
Factors
Scientific uncertainty
Nanotechnology
Regulatory regime

Keywords

  • EU Cosmetic Regulation
  • Health risks
  • Nanomaterials
  • Precautionary principle
  • Regulation
  • US Federal Food, Drug, and Cosmetic Act of 1938
  • US Food and Drug Administration

ASJC Scopus subject areas

  • Economics, Econometrics and Finance(all)
  • Business, Management and Accounting(all)

Cite this

Bowman, D., May, N. D., & Maynard, A. (2017). Nanomaterials in Cosmetics: Regulatory Aspects. In Analysis of Cosmetic Products: Second Edition (pp. 289-302). Elsevier. https://doi.org/10.1016/B978-0-444-63508-2.00012-6

Nanomaterials in Cosmetics : Regulatory Aspects. / Bowman, Diana; May, Nathaniel D.; Maynard, Andrew.

Analysis of Cosmetic Products: Second Edition. Elsevier, 2017. p. 289-302.

Research output: Chapter in Book/Report/Conference proceedingChapter

Bowman, D, May, ND & Maynard, A 2017, Nanomaterials in Cosmetics: Regulatory Aspects. in Analysis of Cosmetic Products: Second Edition. Elsevier, pp. 289-302. https://doi.org/10.1016/B978-0-444-63508-2.00012-6
Bowman D, May ND, Maynard A. Nanomaterials in Cosmetics: Regulatory Aspects. In Analysis of Cosmetic Products: Second Edition. Elsevier. 2017. p. 289-302 https://doi.org/10.1016/B978-0-444-63508-2.00012-6
Bowman, Diana ; May, Nathaniel D. ; Maynard, Andrew. / Nanomaterials in Cosmetics : Regulatory Aspects. Analysis of Cosmetic Products: Second Edition. Elsevier, 2017. pp. 289-302
@inbook{5398fec5a2674e9994c5177a959994b8,
title = "Nanomaterials in Cosmetics: Regulatory Aspects",
abstract = "This chapter examines existing regulatory structures for cosmetic products containing nanomaterials. It does this by first providing a snapshot of the types of nanomaterials that are being incorporated into today's cosmetic products, and the potential benefits thereof. Second, by drawing on the current and projected cosmetic product landscape, it examines how these products fit under existing regulatory arrangements within the United States (US) and the European Union (EU)-the two largest cosmetics markets in the world (by dollar value). As the chapter shows, there is no one-size-fits-all approach to regulating a class of product, and factors beyond just science and scientific uncertainty will drive the design and implementation of a regulatory regime. This is arguably more so, though, with nanotechnology in the US and the EU, given the historical context in which nano-based products are being placed.",
keywords = "EU Cosmetic Regulation, Health risks, Nanomaterials, Precautionary principle, Regulation, US Federal Food, Drug, and Cosmetic Act of 1938, US Food and Drug Administration",
author = "Diana Bowman and May, {Nathaniel D.} and Andrew Maynard",
year = "2017",
month = "11",
day = "17",
doi = "10.1016/B978-0-444-63508-2.00012-6",
language = "English (US)",
isbn = "9780444635082",
pages = "289--302",
booktitle = "Analysis of Cosmetic Products",
publisher = "Elsevier",

}

TY - CHAP

T1 - Nanomaterials in Cosmetics

T2 - Regulatory Aspects

AU - Bowman, Diana

AU - May, Nathaniel D.

AU - Maynard, Andrew

PY - 2017/11/17

Y1 - 2017/11/17

N2 - This chapter examines existing regulatory structures for cosmetic products containing nanomaterials. It does this by first providing a snapshot of the types of nanomaterials that are being incorporated into today's cosmetic products, and the potential benefits thereof. Second, by drawing on the current and projected cosmetic product landscape, it examines how these products fit under existing regulatory arrangements within the United States (US) and the European Union (EU)-the two largest cosmetics markets in the world (by dollar value). As the chapter shows, there is no one-size-fits-all approach to regulating a class of product, and factors beyond just science and scientific uncertainty will drive the design and implementation of a regulatory regime. This is arguably more so, though, with nanotechnology in the US and the EU, given the historical context in which nano-based products are being placed.

AB - This chapter examines existing regulatory structures for cosmetic products containing nanomaterials. It does this by first providing a snapshot of the types of nanomaterials that are being incorporated into today's cosmetic products, and the potential benefits thereof. Second, by drawing on the current and projected cosmetic product landscape, it examines how these products fit under existing regulatory arrangements within the United States (US) and the European Union (EU)-the two largest cosmetics markets in the world (by dollar value). As the chapter shows, there is no one-size-fits-all approach to regulating a class of product, and factors beyond just science and scientific uncertainty will drive the design and implementation of a regulatory regime. This is arguably more so, though, with nanotechnology in the US and the EU, given the historical context in which nano-based products are being placed.

KW - EU Cosmetic Regulation

KW - Health risks

KW - Nanomaterials

KW - Precautionary principle

KW - Regulation

KW - US Federal Food, Drug, and Cosmetic Act of 1938

KW - US Food and Drug Administration

UR - http://www.scopus.com/inward/record.url?scp=85052663613&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052663613&partnerID=8YFLogxK

U2 - 10.1016/B978-0-444-63508-2.00012-6

DO - 10.1016/B978-0-444-63508-2.00012-6

M3 - Chapter

SN - 9780444635082

SP - 289

EP - 302

BT - Analysis of Cosmetic Products

PB - Elsevier

ER -